Could CSL stock be a millionaire-maker at $261

Does the exceptional biotech company still harness the power to make an investment today worth a million in the future?

| More on:
A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Those fortunate enough to have invested $10,000 in Altium Limited (ASX: ALU) over 11 years ago are now sitting on a holding worth more than $1 million. However, investors today might hope to find a millionaire-maker in a more established part of the stock market, such as CSL Limited (ASX: CSL).

The biotechnology giant is no stranger to generating enormous returns for its shareholders either. Since November 2012, the share price of the plasma products maker has risen 442% — exceeding the S&P/ASX 200 Index (ASX: XJO) by a mountainous 386%.

It makes one wonder… could CSL shares be a way of achieving the millionaire milestone without the violent ups and downs?

Going big on a blue-chip

It goes without saying $1 million is a tonne of money. To obtain such a large sum, one usually needs to invest a handsome amount from the outset. Even with $10,000 of hard-earned cash, a 10,000% increase (100 times) return is required to reach a million dollarydoos.

In 2022, the average savings for a man between 30 and 49 years of age was $27,005. Meanwhile, the average savings for a woman of the same age bracket came in at $24,081.

This would imply that even if someone were to plough all their savings (~$25,000) into one stock — which is not advisable — a million dollars remains a 40-fold increase away. It might be a tall order, but it's not out of the realm of possibilities.

In the last 20 years, there have been 10 ASX-listed companies that have experienced a share price increase greater than 4,000%, including:

  • Objective Corporation Ltd (ASX: OCL) – 4,159%
  • Webjet Limited (ASX: WEB) – 5,103%
  • Australian Ethical Investment Ltd (ASX: AEF)

The question then becomes, can the CSL stock price achieve this feat from here?

What would be needed?

Today, CSL shares are fetching $261 apiece. A 40-fold return would see the CSL stock price reach $10,440 — assuming it didn't undergo any stock splits.

This alone doesn't really mean much. Instead, the company's market capitalisation is far more tangible.

The vaccine and drug company is currently valued at $124.1 billion. As such, a millionaire-creating CSL market cap would be $4,964 billion. For context, the most valuable listed company in the world right now is Apple Inc (NASDAQ: APPL) at $4,448 billion.

Assuming CSL traded on a price-to-earnings (P/E) ratio comparable to Apple (31 times), the biotech company would need to produce $160 billion in after-tax earnings if it reached a similar value. That would mean CSL's earnings need to grow nearly 73 times greater than its $2.194 billion in FY2023.

Can CSL stock deliver?

The largest listed pharmaceutical company in the world at present is Eli Lilly and Co (NYSE: LLY). In the latest trailing 12-month period, this behemoth generated nearly US$5 billion in profits.

It's hard to imagine a future where CSL makes 32 times more than the biggest pharma company globally.

Never say never… but investing is a game of probabilities — and I'd say the odds of the CSL stock price increasing 40-fold from here are slim.

In fact, despite its already meteoric run, I'd pick Altium over CSL to be another 40-bagger from here.

Why? Two reasons… the law of large numbers and the remaining runway for growth. As a PCB design software provider, Altium may still have vast opportunities ahead as the world continues to integrate digital components into more items.

Should you invest $1,000 in Appen Limited right now?

Before you buy Appen Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Appen Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Altium, Australian Ethical Investment, CSL, and Objective. The Motley Fool Australia has recommended Australian Ethical Investment, CSL, and Objective. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, holding a mobile phone in his hand while thinking about something.
Opinions

Investing in high-yield ASX stocks has two major negatives

High-yield stocks do have downsides.

Read more »

A young woman in a red polka-dot dress holds an old-fashioned green telephone set in one hand and raises the phone to her ear representing the Telstra share price and the opportunity for investors in FY23
Opinions

The Telstra share price hit a 52-week high this week, is it still a buy?

Is buying Telstra still a good call after its rise?

Read more »

a man puts his hand on the nose of a bull in a lovely green rural setting with the bull raising his nose to meet the man's touch.
Opinions

Why this ASX 300 share looks like a fantastic buy right now

This stock looks like an excellent investment right now.

Read more »

Two female executives looking at a clipboard together.
Opinions

3 ASX share investing lessons from April

April was just one month, but there are multiple lessons from it.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Opinions

Warren Buffett and tariffs: What is his view?

Let’s take a look at what Warren Buffett has said.

Read more »

A susccesful person kicks back and relaxes on a comfy chair
Opinions

If I could only own 1 ASX stock for the next 10 years it would be this one

This business is one of the most appealing investments to me.

Read more »

ETF written on wooden blocks with a magnifying glass.
Opinions

2 beginner ASX shares I'd snap up today

It can be confusing knowing where to start investing. These 2 options look like a great starting place.

Read more »

Yellow rising arrow on a brick wall with a man on a ladder.
Opinions

Will lower interest rates boost Brickworks shares?

Is this business in line to be a major beneficiary of interest rate cuts?

Read more »